Strategic Finance Manager, Vial
+ Equity
Contact research organization for biotech
Job no longer available
Contact research organization for biotech
101-200 employees
Job no longer available
+ Equity
101-200 employees
Company mission
To reimagine clinical trials and deliver faster and more efficient trials for sponsors.
Jump to section
Company mission
To reimagine clinical trials and deliver faster and more efficient trials for sponsors.
Few candidates hear
back within 2 weeks
10% employee growth in 12 months
Our take
Clinical trials can decide the financial success for a drug that takes decades to make, as without them the Food and Drug Administration cannot approve it. Vial organizes the trial process, offering three technology platforms for starting up sites, capturing data and recruiting patients.
The problem currently faced by the biotech industry is that clinical trials are slow-moving and capital-intensive. One inefficiency is the specificity required when cherry-picking the right candidates for a drug. Aiding this process, Vial helps companies find patients across any given country and better collect data that can be organized.
With impressive funding at its disposal, one round recently led by General Catalyst, Vial will continue to help simplify an unorganised industry. With investments in this field becoming increasingly active, Vial is well placed to continue its upwards growth.
Freddie
Company Specialist
Benefits
- Remote-first culture
- Unlimited Vacation
- Exceptional healthcare, dental, and vision coverage
- Paid parental leave
Company values
- Do it Right - Our goal is to build a generational company. We need to be ruthless about being excellent
- Ship It - Move fast. We each operate autonomously within an OKR structure and ultimate vision of the company
- Be Intellectually Honest - Be bold, but operate with integrity and transparency
- Writing is a Superpower - The best decisions start with a well-framed argument in a document
- ABCD (Always Be Connecting Dots) - Relationships are the main driver of performance, not tech
- Structure It - We value structured, well developed thinking. Carefully laid out, deeply contemplated and well reasoned cases are incredibly valuable
- Have Fun! - If something big happens, you can jump up and down and cheer!
Funding (1 round)
Dec 2022
$67m
SERIES B
Total funding: $67m
This company has top investors
Founders
Andrew Brackin
(Co-founder)Previously served as CRO for Vial. Experience as Early Head of Growth for Newfront and as part of the Founding Team for Jobr for Business.
Simon Burns
(CEO & co-founder)Previously acted as Senior Product Manager for Chime and as Product Manager for Opendoor. Co-founded Wealthcoin.